Plant Advanced Technologies SA (ALPAT.PA)
EUR 11.7
(-2.5%)
EUR 11.7
(-2.5%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.22 Million EUR | -34.55% |
| 2022 | 1.87 Million EUR | 4.64% |
| 2021 | 1.78 Million EUR | 9.36% |
| 2020 | 1.63 Million EUR | 83.31% |
| 2019 | 891.91 Thousand EUR | 94171.0% |
| 2018 | 946.12 EUR | -24.05% |
| 2017 | 1245.65 EUR | 16.45% |
| 2016 | 1069.71 EUR | 15.11% |
| 2015 | 929.27 EUR | 20.24% |
| 2014 | 772.85 EUR | -99.89% |
| 2013 | 706.69 Thousand EUR | 3.6% |
| 2012 | 682.11 Thousand EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 FY | 1.22 Million EUR | -34.55% |
| 2023 Q4 | 1.22 Million EUR | 0.0% |
| 2023 Q2 | 1.16 Million EUR | 0.0% |
| 2022 FY | 1.87 Million EUR | 4.64% |
| 2022 Q2 | 1.81 Million EUR | 0.0% |
| 2022 Q4 | 1.87 Million EUR | 0.0% |
| 2021 Q4 | 1.78 Million EUR | 0.0% |
| 2021 FY | 1.78 Million EUR | 9.36% |
| 2021 Q2 | 1.65 Million EUR | 0.0% |
| 2020 Q2 | 1.02 Million EUR | 0.0% |
| 2020 FY | 1.63 Million EUR | 83.31% |
| 2020 Q4 | 1.09 Million EUR | 0.0% |
| 2019 Q2 | 990.83 Thousand EUR | 0.0% |
| 2019 FY | 891.91 Thousand EUR | 94171.0% |
| 2019 Q4 | 891.91 Thousand EUR | 0.0% |
| 2018 Q2 | 1223.56 EUR | 0.0% |
| 2018 FY | 946.12 EUR | -24.05% |
| 2018 Q4 | 946.12 EUR | 0.0% |
| 2017 Q2 | 1147.90 EUR | 0.0% |
| 2017 FY | 1245.65 EUR | 16.45% |
| 2017 Q4 | 1245.65 EUR | 0.0% |
| 2016 Q2 | 955.06 EUR | 0.0% |
| 2016 FY | 1069.71 EUR | 15.11% |
| 2016 Q4 | 1069.71 EUR | 0.0% |
| 2015 FY | 929.27 EUR | 20.24% |
| 2015 Q4 | 929.27 EUR | 0.0% |
| 2015 Q2 | 811.69 EUR | 0.0% |
| 2014 Q4 | 772.85 EUR | 0.0% |
| 2014 Q2 | 742.80 EUR | 0.0% |
| 2014 FY | 772.85 EUR | -99.89% |
| 2013 FY | 706.69 Thousand EUR | 3.6% |
| 2013 Q4 | 706.69 Thousand EUR | 0.0% |
| 2012 FY | 682.11 Thousand EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ABIONYX Pharma SA | 221 Thousand EUR | -454.101% |
| ABIVAX Société Anonyme | 1.00 EUR | -122456200.0% |
| Adocia SA | 272 Thousand EUR | -350.207% |
| Aelis Farma SA | 53 Thousand EUR | -2210.496% |
| Biophytis S.A. | - EUR | -Infinity% |
| Advicenne S.A. | 1.74 Million EUR | 29.663% |
| genOway Société anonyme | 982.75 Thousand EUR | -24.606% |
| IntegraGen SA | 311.44 Thousand EUR | -293.183% |
| Medesis Pharma S.A. | 164.62 Thousand EUR | -643.864% |
| Neovacs S.A. | - EUR | -Infinity% |
| NFL Biosciences SA | -1.1 Million EUR | 210.455% |
| Quantum Genomics Société Anonyme | -119.17 Thousand EUR | 1127.525% |
| Sensorion SA | - EUR | -Infinity% |
| Theranexus Société Anonyme | - EUR | -Infinity% |
| TME Pharma N.V. | 91 Thousand EUR | -1245.674% |
| Valbiotis SA | 1 Million EUR | -21.847% |
| TheraVet SA | 123.34 Thousand EUR | -892.819% |
| Valerio Therapeutics Société anonyme | 1.00 EUR | -122456200.0% |
| argenx SE | 281.12 Million EUR | 99.564% |
| BioSenic S.A. | - EUR | -Infinity% |
| Celyad Oncology SA | 1.26 Million EUR | 2.812% |
| DBV Technologies S.A. | 1.00 USD | -122456200.0% |
| Galapagos NV | 73.97 Million EUR | 98.345% |
| Genfit S.A. | 4000.00 EUR | -30514.075% |
| GeNeuro SA | - EUR | -Infinity% |
| Hyloris Pharmaceuticals SA | 1.00 EUR | -122456200.0% |
| Innate Pharma S.A. | 1.00 EUR | -122456200.0% |
| Inventiva S.A. | 417 Thousand EUR | -193.66% |
| MaaT Pharma SA | 190 Thousand EUR | -544.507% |
| MedinCell S.A. | -6.71 Million EUR | 118.239% |
| Nanobiotix S.A. | 200 Thousand EUR | -512.282% |
| Onward Medical N.V. | 936 Thousand EUR | -30.829% |
| Oryzon Genomics S.A. | 6029.00 EUR | -20211.212% |
| OSE Immunotherapeutics SA | - EUR | -Infinity% |
| Oxurion NV | 128 Thousand EUR | -856.69% |
| Pharming Group N.V. | 51.38 Million EUR | 97.617% |
| Poxel S.A. | 2.95 Million EUR | 58.574% |
| GenSight Biologics S.A. | 1.00 EUR | -122456200.0% |
| Transgene SA | - EUR | -Infinity% |
| Financière de Tubize SA | - EUR | -Infinity% |
| UCB SA | 1.03 Billion EUR | 99.881% |
| Valneva SE | 44.46 Million EUR | 97.246% |
| Vivoryon Therapeutics N.V. | 1.00 EUR | -122456200.0% |